SCHEMBL4570484

SCHEMBL4570484

COC(=O)CCC[C@H](O)C#C[Si](C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.38
PABPC1 P11940 1/20 0.36
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.34
PPARG P37231 1/20 0.34
FPR2 P25090 4/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CA12 O43570 1/20 0.33
CA14 Q9ULX7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30449235 0.95 TSHR (0.44) TSHRL3MBTL1PABPC1APOBEC3AAPOBEC3G
SCHEMBL13305477 0.90 TSHR (0.41) TSHRL3MBTL1PABPC1APOBEC3AAPOBEC3G
SCHEMBL3342037 0.90 TSHR (0.41) TSHRL3MBTL1PABPC1APOBEC3AAPOBEC3G
SCHEMBL30449085 0.88 L3MBTL1 (0.39) TSHRL3MBTL1PABPC1APOBEC3AAPOBEC3G
SCHEMBL3411219 0.84 LMNA (0.49) ALDH1A1LMNAFPR2MAPTHTT
SCHEMBL10427166 0.82 HMGCR (0.43) TSHRL3MBTL1PABPC1APOBEC3AAPOBEC3G
SCHEMBL7405910 0.81 HMGCR (0.45) TSHRALDH1A1PPARGKMT2AHSD17B10
SCHEMBL7405906 0.81 HMGCR (0.45) TSHRALDH1A1PPARGKMT2AHSD17B10
SCHEMBL27409888 0.81 TSHR (0.50) TSHRL3MBTL1PABPC1APOBEC3AAPOBEC3G
SCHEMBL30631093 0.76 TSHR (0.38) TSHRL3MBTL1ALDH1A1LMNAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250288549-A1 SYNTHETIC PROCESS FOR PRODUCTION OF LIPOXIN B4 AND ANALOGUES THEREOF UNIVERSITY HEALTH NETWORK (CA) 2025-09-18 US disclosed
WO-2023205908-A1 SYNTHETIC PROCESS FOR PRODUCTION OF LIPOXIN B4 AND ANALOGUES THEREOF UNIVERSITY HEALTH NETWORK (CA) 2023-11-02 WO disclosed
US-8802874-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-08-12 US disclosed
US-8802874-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2014-08-12 US disclosed
US-8481772-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-07-09 US disclosed
US-8461201-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-06-11 US disclosed
US-8461201-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-06-11 US disclosed
US-20120157700-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2012-06-21 US disclosed
US-20120157700-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2012-06-21 US disclosed
US-20120122816-A1 COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION RESOLVYX PHARMACEUTICALS, INC. (US) 2012-05-17 US disclosed
US-20110295042-A1 METHOD FOR PREPARING PROPARGYLIC ALCOHOL CATALYZED BY 2-MORPHOLINOISOBORNANE-10-THIOL NATIONAL TSING HUA UNIVERSITY (TW) 2011-12-01 US disclosed
US-20110245528-A1 THERAPEUTIC COMPOUNDS SCHWARTZ C ERIC 2011-10-06 US disclosed
US-20110237545-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2011-09-29 US disclosed
US-20110190242-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE RESOLVYX PHARMACEUTICALS, INC. (US) 2011-08-04 US disclosed
US-7902257-B2 Trihydroxy polyunsaturated eicosanoid UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2011-03-08 US disclosed
US-7902257-B2 Trihydroxy polyunsaturated eicosanoid UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2011-03-08 US disclosed
US-20090291916-A1 Trihydroxy Polyunsaturated Eicosanoid UNIVERSITY OF SOUTHERN CALIFORNIA 2009-11-26 US disclosed
US-20090291916-A1 Trihydroxy Polyunsaturated Eicosanoid UNIVERSITY OF SOUTHERN CALIFORNIA 2009-11-26 US disclosed
US-7582785-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-09-01 US disclosed
US-7582785-B2 Trihydroxy polyunsaturated eicosanoid derivatives UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245528-A1 THERAPEUTIC COMPOUNDS ALOX5, ALOX15B, ALOX12 TSHR 3738/4885L3MBTL1 4649/4885PABPC1 3023/4885
US-20110190242-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE ALOX15B, ALOX12, ALOX15 TSHR 4290/4885L3MBTL1 4700/4885PABPC1 4005/4885
US-20110237545-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES ALOX5, ALOX15, ALOX15B TSHR 1001/4885L3MBTL1 4367/4885PABPC1 2940/4885
US-20090291916-A1 Trihydroxy Polyunsaturated Eicosanoid ALOX5, ALOX15, ALOX15B TSHR 1124/4885L3MBTL1 4404/4885PABPC1 2799/4885
US-20250288549-A1 SYNTHETIC PROCESS FOR PRODUCTION OF LIPOXIN B4 AND ANALOGUES THEREOF LTB4R, LTB4R2, ALOX15B TSHR 1182/4885L3MBTL1 1395/4885PABPC1 3609/4885
US-20120122816-A1 COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION ALOX5, ALOX15B, ALOX12 TSHR 4636/4885L3MBTL1 1780/4885PABPC1 2160/4885
US-20110295042-A1 METHOD FOR PREPARING PROPARGYLIC ALCOHOL CATALYZED BY 2-MORPHOLINOISOBORNANE-10-THIOL GRHPR, ADH1C, ADH5 TSHR 290/4885L3MBTL1 91/4885PABPC1 1498/4885
US-20120157700-A1 TRIHYDROXY POLYUNSATURATED EICOSANOID DERIVATIVES ALOX5, ALOX15, ALOX15B TSHR 1001/4885L3MBTL1 4367/4885PABPC1 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.